Table 3.
Within- and between-group interaction effects on frailty, dialysis adequacy, and quality of life (n = 39)
Variable | Time (wk) | Exercise group (n = 18) | Control group (n = 21) | F | p-value | Repeated measures of ANCOVA |
|||
---|---|---|---|---|---|---|---|---|---|
F | p-value | η₂ (f) | |||||||
Frailty (score)a | Baseline | 2.22 ± 1.22 | 2.52 ± 0.87 | 0.35 | 0.56 | Time | 1.80 | 0.17d | 0.048 |
4th | 1.33 ± 1.14c | 2.95 ± 1.02 | 17.52 | <0.001 | Group | 18.55 | <0.001 | 0.340 | |
8th | 1.11 ± 0.90c | 3.05 ± 1.02 | 26.47 | <0.001 | T*G | 21.74 | <0.001d | 0.376 (0.78) | |
12th | 0.94 ± 0.93c | 3.10 ± 1.04 | 34.71 | <0.001 | |||||
Gait speed (m/sec) | Baseline | 0.89 ± 0.22 | 0.83 ± 0.24 | 0.21 | 0.65 | Time | 8.18 | 0.003d | 0.185 |
4th | 1.14 ± 0.30c | 0.76 ± 0.22 | 11.88 | 0.001 | Group | 12.64 | 0.001 | 0.260 | |
8th | 1.18 ± 0.31c | 0.72 ± 0.19 | 20.23 | <0.001 | T*G | 32.2 | <0.001d | 0.464 (0.93) | |
12th | 1.21 ± 0.31c | 0.71 ± 0.19 | 24.26 | <0.001 | |||||
Grip strength (kg) | Baseline | 23.58 ± 9.79 | 26.10 ± 8.83 | 1.27 | 0.27 | Time | 1.92 | 0.15d | 0.051 |
4th | 24.00 ± 9.16 | 21.13 ± 9.51 | 0.18 | 0.68 | Group | 0.05 | 0.83 | 0.001 | |
8th | 25.28 ± 8.45 | 22.40 ± 9.78 | 0.52 | 0.48 | T*G | 9.73 | <0.001d | 0.213 (0.52) | |
12th | 25.61 ± 8.88 | 22.07 ± 8.41 | 0.75 | 0.39 | |||||
Exhaustion (vitality in SF-36, score) | Baseline | 48.46 ± 12.80 | 46.24 ± 10.79 | 1.27 | 0.27 | Time | 1.17 | 0.33 | 0.031 |
4th | 53.16 ± 12.06 | 44.11 ± 9.78 | 7.60 | 0.009 | Group | 9.96 | 0.003 | 0.217 | |
8th | 53.66 ± 8.99 | 41.68 ± 8.34 | 15.08 | <0.001 | T*G | 2.27 | 0.09 | 0.059 (0.25) | |
12th | 53.82 ± 10.06 | 43.26 ± 6.80 | 12.38 | 0.001 | |||||
Weight loss (BMI, kg/m2) | Baseline | 21.55 ± 2.31 | 21.68 ± 3.06 | 0.03 | 0.88 | Time | 3.35 | 0.05d | 0.085 |
4th | 21.53 ± 2.16 | 21.68 ± 3.02 | 0.03 | 0.86 | Group | 0.03 | 0.88 | 0.001 | |
8th | 21.53 ± 2.01 | 21.64 ± 2.77 | 0.04 | 0.84 | T*G | 1.67 | 0.20d | 0.044 (0.21) | |
12th | 21.58 ± 1.98 | 21.79 ± 3.01 | 0.24 | 0.63 | |||||
SPPB (score)b | Baseline | 10.67 ± 1.61 | 10.10 ± 2.02 | 0.07 | 0.79 | Time | 4.31 | 0.03d | 0.009 |
4th | 11.56 ± 0.98c | 9.52 ± 2.06 | 8.73 | 0.005 | Group | 8.73 | 0.006 | 0.142 | |
8th | 11.72 ± 0.67c | 9.86 ± 2.20 | 6.96 | 0.01 | T*G | 28.81 | <0.001d | 0.168 (0.45) | |
12th | 11.83 ± 0.51c | 9.76 ± 2.28 | 9.89 | 0.003 | |||||
Kt/V urea | Baseline | 1.64 ± 0.19 | 1.67 ± 0.19 | 0.14 | 0.71 | Time | 0.46 | 0.67d | 0.013 |
4th | 1.68 ± 0.24 | 1.71 ± 0.24 | 0.05 | 0.82 | Group | 0.29 | 0.59 | 0.008 | |
8th | 1.70 ± 0.23 | 1.71 ± 0.28 | 0.14 | 0.71 | T*G | 2.85 | 0.05d | 0.073 (0.28) | |
12th | 1.76 ± 0.30 | 1.64 ± 0.18 | 2.40 | 0.13 | |||||
Physical component summary | Baseline | 45.51 ± 6.48 | 44.50 ± 8.76 | 1.30 | 0.26 | Time | 5.59 | 0.003d | 0.134 |
4th | 49.41 ± 4.94 | 43.81 ± 7.38 | 8.35 | 0.007 | Group | 8.52 | 0.006 | 0.191 | |
8th | 50.31 ± 4.50 | 44.76 ± 6.88 | 7.41 | 0.01 | T*G | 1.98 | 0.13d | 0.052 (0.23) | |
12th | 51.80 ± 4.51 | 42.79 ± 8.38 | 10.95 | 0.002 | |||||
Mental component summary | Baseline | 50.35 ± 11.04 | 49.81 ± 9.17 | 0.12 | 0.73 | Time | 0.90 | 0.97 | 0.003 |
4th | 53.98 ± 7.83c | 45.22 ± 8.64 | 9.41 | 0.004 | Group | 5.11 | 0.03 | 0.124 | |
8th | 53.24 ± 7.28c | 44.95 ± 8.65 | 7.66 | 0.009 | T*G | 3.04 | 0.03 | 0.078 (0.29) | |
12th | 53.23 ± 8.60 | 48.95 ± 8.14 | 2.92 | 0.10 |
Data are expressed as mean ± standard deviation.
BMI, body mass index; Kt/V, K = dialyzer’s capacity to clear urea at the blood flow rate, t = treatment time, V = distribution volume of urea; SF-36, Short Form-36 tool; SPPB, short physical performance battery; T*G, time*group.
F is effect size calculated using the analysis of covariance (ANCOVA) model adjusted for dialysis vintage in G*Power (small = 0.10, medium = 0.25, large = 0.40); F-score calculated using ANCOVA adjusted by dialysis vintage (exercise group vs. control group).
Score range:
0–5,
0–12.
Statistically significant based on Bonferroni correction (p < 0.013);
Greenhouse-Geisser correction according to Mauchly’s sphericity test (p < 0.05).